Clinical trial
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical…
NCT00002562 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002562 |
|---|---|
| Title | Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer |
| Official title | EVALUATION OF PACLITAXEL (TAXOL) IN PERSISTENT OR RECURRENT NON-SQUAMOUS CELL CARCINOMA OF THE CERVIX AND VAGINA |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Vaginal Cancer |
| Intervention type | Drug |
| Interventions | paclitaxel |
| Enrollment | 25 |
| Start date | Mar 1, 1994 |
| Completion | Aug 1, 2004 |
| First posted | Aug 10, 2004 |
| Last update posted | Jun 20, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: